Canadian HIV pregnancy planning guidelines: No. 278, June 2012

International Journal of Gynecology and Obstetrics

Volumn 119, Issue 1, 2012, Pages 89-99

  Loutfy, Mona R ^a   Margolese, Shari ^a   Money, Deborah M ^a   Gysler, Mathias ^a   Hamilton, Scot ^a   Yudin, Mark H ^a  

^a NONE

Author keywords

Fertility; HIV; Insemination; Pregnancy; Transmission

Indexed keywords

ANTIRETROVIRUS AGENT; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOPTION; ARTIFICIAL INSEMINATION; CANADA; CONCEPTION; CONTRACEPTION; DRUG SAFETY; FAMILY HEALTH; FAMILY PLANNING; FERTILITY; FERTILIZATION IN VITRO; HEALTH CARE PERSONNEL; HETEROSEXUALITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RIGHTS; INFECTION CONTROL; INFECTION PREVENTION; INFERTILITY; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; INTRAUTERINE INSEMINATION; MATERNAL WELFARE; MEDICAL ETHICS; MENTAL HEALTH; OUTCOME ASSESSMENT; PARENTHOOD; PATIENT COUNSELING; PRACTICE GUIDELINE; PREGNANCY; PRENATAL CARE; PRIORITY JOURNAL; REPRODUCTIVE HEALTH; REVIEW; RISK REDUCTION; SEXUAL TRANSMISSION; SINGLE MAN; SINGLE WOMAN; SOCIAL PSYCHOLOGY; SPERM DONOR; UNWANTED PREGNANCY; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

EID: 84865974834     PISSN: 00207292     EISSN: 18793479     Source Type: Journal    
DOI: 10.1016/j.ijgo.2012.06.004     Document Type: Review

References (80)

1. Palella Jr. FJ, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006;43:27-34.
2. Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d'Arminio Monforte A, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 2003;362(9377):22-9.
3. The Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 2008;372(9635):293-9.
4. Public Health Agency of Canada. HIV and AIDS in Canada. Surveillance report to December 31, 2007. Ottawa: Surveillance and Risk Assessment Division, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada; 2008. Available at: http://www.phac-aspc.gc.ca/aids-sida/publication/ survreport/2007/surveillance-2007-10-eng.php. Accessed April 25, 2011.
5. Public Health Agency of Canada. HIV and AIDS in Canada. Surveillance Report to December 31, 2008. Surveillance and Risk Assessment Division, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada; 2009. Available at: http://www.phac-aspc.gc.ca/aids-sida/publication/ survreport/2008/dec/pdf/survrepdec08.pdf. Accessed April 25 2011.
6. Tharao W, Logie C, James L, Loutfy M. "These are some of the things we need": women living with HIV discuss issues in their daily lives as research priorities. Oral abstract presented at Canadian Association for AIDS Researchers Conference Toronto; 2011.
7. Ogilvie GS, Palepu A, Remple VP, Maan E, Heath K, MacDonald G, et al. Fertility intentions of women of reproductive age living with HIV in British Columbia, Canada. AIDS 2007;21(Suppl. 1):583-8.
8. Loutfy MR, Hart TA, Mohammed SS, Su D, Ralph ED, Walmsley SL, et al. Fertility desires and intentions of HIV-positive women of reproductive age in Ontario, Canada: a crosssectional study. PLoS One 2009;4(12):e7925.
9. Oladapo OT, Daniel OJ, Odusoga OL, Ayoola-Sotubo O. Fertility desires and intentions of HIV-positive patients at a suburban specialist center. J Natl Med Assoc 2005;97:1672-81.
10. Nattabi B, Li J, Thompson SC, Orach CG, Earnest J. A systematic review of factors influencing fertility desires and intentions among people living with HIV/AIDS: implications for policy and service delivery. AIDS Behav 2009;13(5):949-68.
11. Semprini AE, Levi-Setti P, Bozzo M, Ravizza M, Taglioretti A, Sulpizoo P, et al. Insemination of HIV-negative women with processed semen of HIV-positive partners. Lancet 1992;340:1317-9.
12. SauerMV,Wang JG,DouglasNC,Nakhuda GS, Vardhana P, JovanovicV, et al. Providing fertility care to men seropositive for human immunodeficiency virus: reviewing years of experience and 420 consecutive cycles of in vitro fertilization and intracytoplasmic sperm injection. Fertil Steril 2009;91(6):2455-60.
13. Yudin MH, Shapiro HM, Loutfy MR. Access to infertility services in Canada for HIV-positive individuals and couples: a cross-sectional study. Reprod Health 2010;7:7. doi:10.1186/1742-4755-7-7.
14. Newmeyer T, Tecimer SN, Jaworsky D, Chihrin S, Gough K, Rachlis A, et al. Case series of fertility treatment in HIV-discordant couples (male positive, female negative): the Ontario experience. PLoS One 2011;6(9):e24853.
15. Loutfy M, Rouboud J, Wong J, Yudin M, Diong C, Blitz S, et al. High prevalence of unintended pregnancies in HIV-positive women of reproductive age in Ontario, Canada: a retrospective study. HIV Med 2012;13(2):107-17.
16. Wilcher R, Cates W. Reproductive choices for women with HIV. Bull World Health Organ 2009;87(11):833-9.
17. O'Bryan T, Jadavji T, Kim J, Gill MJ. An avoidable transmission of HIV from mother to child. CMAJ 2011;183:690-2.
18. Burdge DR, Money DM, Forbes JC, Walmsley SL, Smaill FM, Boucher M, et al. Canadian consensus guidelines for the management of pregnant HIV-positive women: putting recommendations into practice. CMAJ 2003;168(13):1683-8 Revised: June 24, 2003].
19. Canadian Fertility and Andrology Society website]. Available at: http://www.cfas. ca. Accessed June 10, 2011.
20. Public Health Agency of Canada. What is fetal alcohol spectrum disorder (FASD)? Available at: http://www.phac-aspc.gc.ca/hp-ps/dca-dea/prog-ini/fasd- etcaf/publications/fs-fi-01-eng.php. Accessed April 16, 2012.
21. Public Health Agency of Canada. The sensible guide to a healthy pregnancy. Available at: http://www.phac-aspc.gc.ca/hp-gs/guide-eng.php Accessed April 19, 2011.
22. The Society of Obstetricians and Gynecologists of Canada. Clinical Practice Guidelines. Available at http://www.sogc.org/guidelines/index-e.asp. Accessed October 6, 2011.
23. Britton JR. Pre-discharge anxiety among mothers of well newborns: prevalence and correlates. Acta Paediatr 2005;94:1771-6.
24. Britton JR. Maternal anxiety: course and antecedents during the early postpartum period. Depress Anxiety 2008;25:793-800.
25. Clinton JF, Kelber ST. Stress and coping in fathers of newborns: comparisons of planned versus unplanned pregnancy. Int J Nurs Stud 1993;30(5):437-43.
26. Bell E, Mthembu P, O'Sullivan S. Sexual and reproductive health services and HIV testing: perspectives and experiences of women and men living with HIV and AIDS. Reprod Health Matters 2007;15(29 Suppl.):113-35.
27. Nduna M, Farlane L. Women living with HIV in South Africa and their concerns about fertility. AIDS Behav 2009;13(Suppl. 1):62-5.
28. Bharat S, Mahendra V. Meeting the sexual and reproductive heath needs of people living with HIV: challenges for health providers. Reprod Health Matters 2007;15(29 Suppl.):93-112.
29. Bartell S. On becoming a mother: the psychological journey. Int J Childbirth Educ 2005;20(1):28-30.
30. Clement S, Sikorski J, Wilson J, Das S. Planning antenatal services to meet women's psychological needs. Br J Midwifery 1997;5(5):298-302.
31. Deave T, Johnson D, Ingram J. Transition to parenthood: the needs of parents in pregnancy and early parenthood. BMC Pregnancy Childbirth 2008;8(30):1-11.
32. Blaney N. Psychosocial and behavioral correlates of depression among HIV-infected pregnant women. AIDS Patient Care STDS 2004;18(7):405.
33. Larrabee K, Monga M, Eriksen N, Helfgott A. Quality of life assessment in pregnant women with the human immunodeficiency virus. Obstet Gynecol 1996;88(6): 1016-20.
34. Clinton JF, Kelber ST. Stress and coping in fathers of newborns: comparisons of planned versus unplanned pregnancy. Int J Nurs Stud 1993;30(5):437-43.
35. Greening L. And-how was it for you, dad? Community Pract 2006;79(6):184-7.
36. Matthey S, Barnett B, Ungerer J, Waters B. Paternal and maternal depressed mood during the transition to parenthood. J Affect Disord 2000;60:75-85.
37. Ramchandani P, Stein A, Evans J, O'Connor TG. Paternal depression in the postnatal period and child development: a prospective population study. Lancet 2005;365: 2201-5.
38. Medley A, Garcia-Moreno C, McGill S, Maman S. Rates, barriers and outcomes of HIV serostatus disclosure among women in developing countries: implications for prevention of mother-to-child transmission programmes. Bull World Health Organ 2004;82:299-307.
39. R. v. Cuerrier, 1998 2 S.C.R. 371. Available at: http://www.canlii.org/ en/ca/scc/doc/1998/1998canlii796/1998canlii796.html. Accessed April 16, 2012.
40. Symington A. Criminalization confusion and concerns: the decade since the Cuerrier decision. HIV AIDS Policy Law Rev 2009;14(1):1-10 Canadian HIV/AIDS Legal Network.
41. Vernazza P, Hirschel B, Bernasconi E, Flepp M. Les Personnes séropositives ne souffrant d'aucune autre MST et suivant un traitement antirétroviral efficace ne transmettent pas le VIH par voie sexuelle. Bull Med Suisses 2008;89(5):165-9.
42. United Nations AIDS. Criminalization of HIV transmission. UNAIDS Policy Brief; 2008.
43. Priest L. Mother avoiding AZT. The Globe and Mail; April 2006.
44. Williams H, Watkins C, Risby J. Reproductive decision-making and determinants of contraceptive use in HIV-infected women. Clin Obstet Gynecol 1996;39(2): 333-43.
45. United Nations Entity for Gender Equality and the Empowerment of Women. Convention on the elimination of all forms of discrimination against women. Article 16.1; 1979.
46. Tubiana R. Extremely low risk of MTCT of HIV in women starting HAART before pregnancy: French Perinatal Cohort, ANRS EPF C01/11. Abstract presented at the 18th Conference on Retroviruses and Opportunistic Infections, Boston,Massachusetts, February 27 to March 2, 2011; 2011. Available at: http://www.retroconference.org/2011/Abstracts/41451.htm. Accessed June 14, 2011.
47. Angel JB, Hu YW, Kravcik S, Tsui R, Lee KH, Barbour J, et al. Virological evaluation of the Ottawa case indicates no evidence for HIV-1 superinfection. AIDS 2004;18(2): 331-4.
48. Angel JB, Kravcik S, Balaskas E, Yen P, Badley AD, CameronDW, et al. Documentation of HIV-1 superinfection and acceleration of disease progression. Abstract presented at 7th Conference on Retroviruses and Opportunistic Infections; February 2 2000. San Francisco CA.
49. Blackard JT, Cohen DE, Mayer KH. Human immunodeficiency virus superinfection and recombination: current state of knowledge and potential clinical consequences. Clin Infect Dis 2002;34(8):1108-14.
50. The United States Centers for Disease Control and Prevention. Interim guidance: preexposure prophylaxis for the prevention of HIV infection inmen who have sex with men. MMWR Morb Mortal Wkly Rep 2011;60(03):60-8 Available at: http://www. cdc.gov/mmwr/preview/mmwrhtml/mm6003a1.htm. Accessed April 14, 2011.
51. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010;363:2587-99.
52. The United States Centers for Disease Control and Prevention. Results of FEM-PrEP clinical trial examining pre-exposure prophylaxis (PrEP) for HIV prevention among heterosexual women. Available at http://www.cdc.gov/hiv/prep/ femprep.htm. Accessed April 14, 2011.
53. Barreiro P, Castilla JA, Labarga P, Soriano V. Is natural conception a valid option for HIV-serodiscordant couples? Hum Reprod 2007;22(9):2353-8.
54. Barreiro P, del Romero J, Leal M, Hernando V, Asencio R, de Mendoza C, et al. Natural pregnancies in HIV-serodiscordant couples receiving successful antiretroviral therapy. J Acquir Immune Defic Syndr 2006;43(3):324-6.
55. Melo MG, Santos BR, De Cassia Lira R, Varella IS, Turella ML, Rocha TM, et al. Sexual transmission of HIV-1 among serodiscordant couples in Porto Alegre, southern Brazil. Sex Transm Dis 2008;35(11):912-5.
56. Hart CE, Lennox JL, Pratt-Palmore M, Wright TC, Schinazi RF, Evans-Strickfaden T. Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract. J Infect Dis 1999;179(4):871-82.
57. Public Health Agency of Canada. HIV/AIDS Epi Updates, December 2007. Available at http://www.phac-aspc.gc.ca/aids-sida/publication/index-eng.php. Accessed March 21, 2012.
58. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000;342(13):921-9.
59. Fiore JR, Suligoia B, Saracinob A, Stefanob MD, Bugarinia R, Leperac A, et al. Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies. AIDS 2003;17(15):2169-76.
60. Anglemyer A, Rutherford GW, Baggaley RC, Egger M, Siegfried N. Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples. Cochrane Database Syst Rev 2011;8:CD009153.
61. Liuzzi G, Chirianni A, Clementi M, Bagnarelli P, Valenza A, Cataldo PT, et al. Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study. AIDS 1996;10:51-6.
62. Coombs RW, Speck CE, Hughes JP, Lee W, Sampoleo R, Ross SO, et al. Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood. J Infect Dis 1998;177:320-30.
63. Vitorino RL, Grinsztejn BG, de Andrade CA, Hkerberg YH, de Souza CT, Friedman RK, et al. Systematic review of the effectiveness and safety of assisted reproduction techniques in couples serodiscordant for human immunodeficiency virus where the man is positive. Fertil Steril 2011;95:1684-90.
64. Al-Khan A, Colon J, Palta V, Bardeguez A. Assisted reproductive technology for men and women infected with human immunodeficiency virus type 1. Clin Infect Dis 2003;36(2):195-200.
65. Bagasra O, Farzadegan H, Seshamma T, Oakes JW, Saah A, Pomerantz RJ. Detection of HIV-1 proviral DNA in sperm from HIV-1-infected men. AIDS 1994;8(12): 1669-74.
66. Baker HW, Mijch A, Garland S, Crowe S, Dunne M, Edgar D, et al. Use of assisted reproductive technology to reduce the risk of transmission of HIV in discordant couples wishing to have their own children where the male partner is seropositive with an undetectable viral load. J Med Ethics 2003;29(6):315-20.
67. Bujan L, Hollander L, Coudert M, Gilling-Smith C, Vucetich A, Guibert J, et al. Safety and efficacy of sperm washing in HIV-1-serodiscordant couples where the male is infected: results from the European CREAThE network. AIDS 2007;21(14): 1909-14.
68. Bujan L, Pasquier C, Labeyrie E, Lanusse-Crousse P, Morucci M, Daudin M. Insemination with isolated and virologically tested spermatozoa is a safe way for human immunodeficiency type 1 virus- serodiscordant couples with an infected male partner to have a child. Fertil Steril 2004;82(4):857-62.
69. Bujan L, SergerieM, KifferN,MoinardN, Seguela G,Mercadier B, et al.Good efficiency of intrauterine insemination programme for serodiscordant couples with HIV-1 infected male partner: a retrospective comparative study. Eur J Obstet Gynecol Reprod Biol 2007;135(1):76-82.
70. Barreiro P, Duerr A, Beckerman K, Soriano V. Reproductive options for HIV serodiscordant couples. AIDS Rev 2006;8(3):158-70.
71. Garrido N, Gil-Salom M, Martínez-Jabaloyas JM, Meseguer M. First report of the absence of viral load in testicular sperm samples obtained from men with hepatitis C and HIV after washing and their subsequent use. Fertil Steril 2009;92(3): 1012-5.
72. Garrido N, Meseguer M, Bellver J, Remohí J, Simón C, Pellicer A. Report of the results of a 2 year programme of sperm wash and ICSI treatment for human immunodeficiency virus and hepatitis C virus serodiscordant couples. Hum Reprod 2004;19(11):2581-6.
73. Savasi V, Ferrazzi E, Lanzani C, Oneta M, Parrilla B, Persico T. Safety of sperm washing and ART outcome in 741 HIV-1-serodiscordant couples. Hum Reprod 2007;22(3):772-7.
74. Kim LU, Johnson MR, Barton S, Nelson MR, Sontag G, Smith JR, et al. Evaluation of sperm washing as a potential method of reducing HIV transmission in HIV-discordant couples wishing to have children. AIDS 1999;13(6):645-51.
75. Lasheeb AS, King J, Ball JK, Curran R, Barratt CL, Afnan M, et al. Semen characteristics inHIV-1 positivemen and the effect of semenwashing. GenitourinMed 1997;73(4): 303-5.
76. Hanabusa H, Kuji N, Kato S, Tagami H, Kaneko S, Tanaka H, et al. An evaluation of semen processing methods for eliminating HIV-1. AIDS 2000;14(11):1611-6.
77. Kashima K, Takakuwa K, Suzuki M, Makino M, Kaneko S, Kato S, et al. Studies of assisted reproduction techniques (ART) for HIV-1-discordant couples using washed sperm and the nested PCR method: a comparison of the pregnancy rates in HIV-1-discordant couples and control couples. Jpn J Infect Dis 2009;62(3): 173-6.
78. Loutradis D, Drakakis P, Kallianidis K, Patsoula E, Bletsa R, Michalas S. Birth of two infants who were seronegative for human immunodeficiency virus type 1 (HIV-1) after intracytoplasmic injection of sperm from HIV-1-seropositive men. Fertil Steril 2001;75(1):210-2.
79. Adoption Council of Canada. Adoption in Canada. Available at:http://www. adoption.ca/adoption-in-canada Accessed April 12, 2012.
80. Woolf SH, Battista RN, Angerson GM, Logan AG, Eel W. Canadian Task Force on Preventive Health Care. New grades for recommendations from the Canadian Task Force on Preventive Health Care. CMAJ 2003;169:207-8.